⭐ Top Story
Organigram’s U.S. Pivot Signals End of Canadian Export-First Strategy
By Sheeba M. | April 26, 2026 Organigram’s U.S. Pivot Signals End of Canadian Export-First Strategy TL;DR: Organigram and Canopy Growth shift strategy toward U.S.
Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results
By Sheeba M. | April 26, 2026 Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results TL;DR: Multi-state operators report Q1 earnings
Cannabis Stocks Rally on Rescheduling: Here’s What Actually Changes
By Sheeba M. | April 25, 2026 “Marijuana Rescheduling: Initial Rally Fades as Market Digests Reality” TL;DR Cannabis stocks spiked on DOJ reclassification to Schedule
📈 Top Movers
Organigram’s U.S. Pivot Signals End of Canadian Export-First Strategy
By Sheeba M. | April 26, 2026 Organigram’s U.S. Pivot Signals End of Canadian Export-First Strategy TL;DR: Organigram and Canopy Growth shift strategy toward U.S.
Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results
By Sheeba M. | April 26, 2026 Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results TL;DR: Multi-state operators report Q1 earnings
GLP-1 Diet Drugs Are Killing Cannabis Sales (Here’s Why)
By Sheeba M. | April 25, 2026 “GLP-1 Weight Loss Boom Quietly Reshaping the $40B Cannabis Market” TL;DR Dispensaries are adjusting product offerings as GLP-1
Cannabis M&A Isn’t Dead—It’s Just Invisible Now
By Sheeba M. | April 25, 2026 “Why Cannabis M&A in 2026 Will Look Nothing Like Past Deals” TL;DR April 2026 saw 11 cannabis transactions,
Canopy Growth Stock Surged 25%: Should You Care?
By Sheeba M. | April 25, 2026 “Dead Cat Bounce or Real Rally? Why Canopy Growth (CGC) Deserves Caution” TL;DR Canopy Growth is up 25%
📰 Today's News
Organigram’s U.S. Pivot Signals End of Canadian Export-First Strategy
By Sheeba M. | April 26, 2026 Organigram’s U.S. Pivot Signals End of Canadian Export-First Strategy TL;DR: Organigram and Canopy Growth shift strategy toward U.S.
Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results
By Sheeba M. | April 26, 2026 Cannabis MSO Earnings Wave: Margin Pressure and Strategic Pivots Dominate Q1 Results TL;DR: Multi-state operators report Q1 earnings
The Cannabis Cash Flow Story Nobody’s Talking About: Why EBITDA Is the New EPS
By Sheeba M. | April 26, 2026 The Cannabis Cash Flow Story Nobody’s Talking About: Why EBITDA Is the New EPS TL;DR: Section 280E is
Cresco Labs Earnings Beat Sparks Rally as Margin Expansion Accelerates
By Sheeba M. | April 26, 2026 Cresco Labs Earnings Beat Sparks Rally as Margin Expansion Accelerates TL;DR: Cresco Labs posted Q1 2026 revenue of
Hemp’s Regulatory Time Bomb: November 2026 Changes Set to Reshape the Market
By Sheeba M. | April 26, 2026 Hemp’s Regulatory Time Bomb: November 2026 Changes Set to Reshape the Market TL;DR: New hemp-derived THC thresholds take
Medical Cannabis Rescheduling: The DEA’s Historic Move and What Investors Should Know
By Sheeba M. | April 26, 2026 Medical Cannabis Rescheduling: The DEA’s Historic Move and What Investors Should Know TL;DR: The DEA officially moved medical